Skip to main content
Log in

The role of glutamate in the locus coeruleus during opioid withdrawal and effects of H-7, a protein kinase inhibitor, on the action of glutamate in rats

  • Original Paper
  • Published:
Journal of Biomedical Science

Abstract

To investigate the role of glutamate in the locus coeruleus (LC) during opioid withdrawal, rats were continuously infused with morphine (a μ-opioid receptor agonist, 26 nmol/µl/h) or butorphanol (a μ/δ/κ-mixed opioid receptor agonist, 26 nmol/µl/h) intracerebroventricularly (i.c.v.) via osmotic minipumps for 3 days. A direct LC injection of glutamate (1 or 10 nmol/5 µl) or naloxone (an opioid receptor antagonist, 24 nmol/5 µl) induced withdrawal signs in morphine- or butorphanol-dependent animals. However, these agents failed to precipitate any withdrawal signs in saline-treated control animals. On the other hand, the expression of withdrawal signs precipitated by the administration of glutamate or naloxone in opioid-dependent animals was completely blocked by concomitant infusion with 1 or 10 nmol/µl/h of an inhibitor of adenosine 3′,5′-cyclic monophosphate (cAMP)-dependent protein kinase and protein kinase C, H-7 [1-(5-isoquinolinesulfonyl)-2-methylpiperazine]. In animals that had been infused with opioids in the same manner, i.c.v. injection of naloxone (48 nmol/5 µl) precipitated withdrawal signs and increased extracellular fluid levels of glutamate in the LC of morphine- or butorphanol-dependent rats measured by in vivo microdialysis method. However, concomitant infusion with H-7 inhibited the increases of glutamate levels in the LC. These results strongly suggest that an expeditious release of glutamate in the LC region plays an important role in the expression of physical dependence on opioids. Furthermore, the action on glutamate release might be increased by the enhancement of cAMP-dependent protein kinase and/or protein kinase C activity.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Aghajanian GK. Tolerance of locus coeruleus neurons to morphine and suppression of withdrawal response by clonidine. Nature 276:186–188;1978.

    Google Scholar 

  2. Aghajanian GK, Kogan JH, Moghaddam B. Opiate withdrawal increases glutamate and aspartate efflux in the locus coeruleus: An in vivo microdialysis study. Brain Res 636:126–130;1994.

    Google Scholar 

  3. Akaoka H, Aston-Jones G. Opiate withdrawal-induced hyperactivity of locus coeruleus neurons is substantially mediated by augmented excitatory amino acid input. J Neurosci 11:3830–3839;1991.

    Google Scholar 

  4. Aston-Jones G, Ennis M, Pieribone VA, Nickell WT, Shipley MT. The brain nucleus locus coeruleus: Restricted afferent control of a broad efferent network. Science 234:734–737;1986.

    Google Scholar 

  5. Atweh SF, Kuhar MJ. Autoradiographic localization of opioid receptors in rat brain. II. The brain stem. Brain Res 129:1–12;1977.

    Google Scholar 

  6. Chen L, Huang LM. Sustained potentiation of NMDA receptor-mediated glutamate response through activation of protein kinase C by a μ opioid. Neuron 7:319–326;1991.

    Google Scholar 

  7. Dahlstrom A, Fuxe L. Evidence for the existence of monoamine-containing neurons in the central nervous system. I. Demonstration of monoamines in the cell bodies of brain stem neurons. Acta Physiol Scand 62, Suppl. 232 (1):1–55;1964.

    Google Scholar 

  8. Ellison DW, Beal MF, Martin JB. Amino acid neurotransmitters in postmortem human brain analyzed by high performance liquid chromatography with electrochemical detection. J Neurosci Methods 19:305–315;1987.

    Google Scholar 

  9. Ennis M, Aston-Jones G. Activation of locus coeruleus from nucleus paragigantocellularis: A new excitatory amino acid pathway in brain. J Neurosci 8:3644–3657;1988.

    Google Scholar 

  10. Esposito E, Kruszzewska A, Ossowska G, Samanin R. Noradrenergic and behavioural effects of naloxone injected in the locus coeruleus of morphine-dependent rats and their control by clonidine. Psychopharmacology 93:393–396;1987.

    Google Scholar 

  11. Feng YZ, Zhang T, Rockhold RW, Ho IK. Increased locus coeruleus glutamate levels are associated with naloxone-precipitated withdrawal from butorphanol in the rat. Neurochem Res 20:745–751;1995.

    Google Scholar 

  12. Feng YZ, Zhang T, Tokuyama S, Zhu H, Rockhold RW, Ho IK. μ- and δ-opioid receptor antagonists precipitate similar withdrawal phenomena in butorphanol and morphine dependence. Neurochem Res 21:63–71;1996.

    Google Scholar 

  13. Garland LG, Bonser RW, Thompson NT. Protein kinase C inhibitors are not selective. Trends Pharmacol Sci 8:334;1987.

    Google Scholar 

  14. Gucker S, Bidlack JM. Protein kinase C activation increases the rate and magnitude of agonist-induced δ-opioid receptor down-regulation in NG108-15 cells. Mol Pharmacol 42:656–665;1992.

    Google Scholar 

  15. Hidaka H, Inagaki M, Kawamoto S, Sasaki Y. Isoquinolinesulfonamides, novel and potent inhibitors of cyclic nucleotide protein kinase and protein kinase C. Biochemistry 23:5036–5041;1984.

    Google Scholar 

  16. Honore T, Davies SN, Drejer J, Fletcher EJ, Jacobsen P, Lodge D, Nielsen FE. Quinoxalinediones: Potent competitive non-NMDA glutamate receptor antagonist. Science 241:701–703;1988.

    Google Scholar 

  17. Jaw SP, Hoskins B, Ho IK. Involvement of δ-opioid receptors in physical dependence on butorphanol. Eur J Pharmacol 240:67–72;1993.

    Google Scholar 

  18. Jaw SP, Makimura M, Hoskins B, Ho IK. Effect of nor-binaltorphimine on butorphanol dependence. Eur J Pharmacol 239:133–140;1993.

    Google Scholar 

  19. Johnson JW, Ascher P. Glycine potentiates the NMDA response in cultured mouse brain neurons. Nature 325:529–531;1987.

    Google Scholar 

  20. Kogan JH, Nestler EJ, Aghajanian GK. Elevated basal firing rates and enhanced responses to 8-Br-cAMP in locus coeruleus in brain slices from opiate-dependent rats. Eur J Pharmacol 211:47–53;1992.

    Google Scholar 

  21. Lodge D, Collingridge G. The pharmacology of excitatory amino acids: A TIPS special report. Trends Pharmacol Sci (Elsevier Trends Journals, Cambridge, UK), 1991.

    Google Scholar 

  22. Maldonado R, Stinus L, Gold LH, Koob GF. Role of different brain structures in the expression of the morphine physical withdrawal syndrome. J Pharmacol Exp Ther 261:669–677;1992.

    Google Scholar 

  23. Nestler EJ, Hope BT, Widnell KL. Drug addiction: A model for molecular basis of neural plasticity. Neuron 11:995–1006;1993.

    Google Scholar 

  24. Nestler EJ, Tallman JF. Chronic morphine treatment increases cyclic AMP-dependent protein kinase activity in the rat locus coeruleus. Mol Pharmacol 33:127–132;1988.

    Google Scholar 

  25. Paxinos G, Watson C. The rat brain in stereotaxic coordinates. 2nd ed. Orlando, FL, Academic Press, 1986.

    Google Scholar 

  26. Rasmussen K, Aghajanian GK. Withdrawal-induced activation of locus coeruleus neurons in opiate-dependent rats: Attenuation by lesions of the nucleus paragigantocellularis. Brain Res 505:346–350;1989.

    Google Scholar 

  27. Rasmussen K, Beitner-Johnson DB, Krystal JH. Opiate withdrawal and the rat locus coeruleus: Behavioral, electrophysiological and biochemical correlates. J Neurosci 10:2308–2317;1990.

    Google Scholar 

  28. Redmond DE Jr, Huang YH, Snyder DR, Maas JW. Behavioral effects of stimulation of the nucleus locus coeruleus in the stump-tailed monkey(Macaca arctoides). Brain Res 116:502–510;1976.

    Google Scholar 

  29. Redmond DE Jr, Krystal JH. Multiple mechanisms of withdrawal from opioid drugs. Annu Rev Neurosci 7:443–478;1984.

    Google Scholar 

  30. Schoepp DD, Conn PJ. Metabotropic glutamate receptors in brain function and pathology. Trends Pharmacol Sci 14:13–20;1993.

    Google Scholar 

  31. Tanganelli S, Antonelli T, Morari M, Bianchi C, Beani L. Glutamate antagonists prevent morphine withdrawal in mice and guinea pigs. Neurosci Lett 122:270–272;1991.

    Google Scholar 

  32. Tempel A, Zukin RS. Neuroanatomical patterns of the μ, δ and κ opioid receptors of rat brain as determined by quantitative in vitro autoradiography. Proc Natl Acad Sci USA 84:4308–4312;1987.

    Google Scholar 

  33. Tokuyama S, Feng YZ, Wakabayashi H, Ho IK. Ca2+ channel blocker, diltiazem, prevents physical dependence and the enhancement of protein kinase C activity by opioid infusion in rats. Eur J Pharmacol 279:93–98;1995.

    Google Scholar 

  34. Tokuyama S, Feng YZ, Wakabayashi H, Ho IK. Possible involvement of protein kinases in physical dependence on opioids: Studies using protein kinase inhibitors, H-7 and H-8. Eur J Pharmacol 284:101–107;1995.

    Google Scholar 

  35. Tokuyama S, Wakabayashi H, Ho IK. Direct evidence for a role of glutamate in the expression of the opioid withdrawal syndrome. Eur J Pharmacol 295:123–129;1996.

    Google Scholar 

  36. Wang Z, Bilsky EJ, Porreca F, Sadee W. Constitutive μ opioid receptor activation as a regulatory mechanism underlying narcotic tolerance and dependence. Life Sci 54:339–350;1994.

    Google Scholar 

  37. Watkins JC, Krogsgaard-Larsen P, Honore T. Structure-activity relationships in the development of excitatory amino acid receptor agonists and competitive antagonists. In: Lodge D, Collingridge G, eds. The Pharmacology of Excitatory Amino Acids. Tips Special Report. Cambridge, Elsevier, 4: 1990.

    Google Scholar 

  38. Zhang T, Feng YZ, Rockhold RW, Ho IK. Naloxone-precipitated morphine withdrawal increases pontine glutamate levels in the rat. Life Sci 55:25–31;1994.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tokuyama, S., Zhu, H., Wakabayashi, H. et al. The role of glutamate in the locus coeruleus during opioid withdrawal and effects of H-7, a protein kinase inhibitor, on the action of glutamate in rats. J Biomed Sci 5, 45–53 (1998). https://doi.org/10.1007/BF02253355

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02253355

Key Words

Navigation